Literature DB >> 27055367

Mechanisms of prion-induced neurodegeneration.

Paula Saá1, David A Harris2, Larisa Cervenakova1.   

Abstract

Transmissible spongiform encephalopathies (TSEs), or prion diseases, are fatal neurodegenerative disorders characterised by long incubation period, short clinical duration, and transmissibility to susceptible species. Neuronal loss, spongiform changes, gliosis and the accumulation in the brain of the misfolded version of a membrane-bound cellular prion protein (PrP(C)), termed PrP(TSE), are diagnostic markers of these diseases. Compelling evidence links protein misfolding and its accumulation with neurodegenerative changes. Accordingly, several mechanisms of prion-mediated neurotoxicity have been proposed. In this paper, we provide an overview of the recent knowledge on the mechanisms of neuropathogenesis, the neurotoxic PrP species and the possible therapeutic approaches to treat these devastating disorders.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27055367     DOI: 10.1017/erm.2016.8

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  14 in total

Review 1.  Lysosomal Quality Control in Prion Diseases.

Authors:  Priyanka Majumder; Oishee Chakrabarti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

Review 2.  Small-molecule PET Tracers for Imaging Proteinopathies.

Authors:  Chester A Mathis; Brian J Lopresti; Milos D Ikonomovic; William E Klunk
Journal:  Semin Nucl Med       Date:  2017-07-13       Impact factor: 4.446

3.  An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease.

Authors:  Leonardo Iaccarino; Rosa Maria Moresco; Luca Presotto; Orso Bugiani; Sandro Iannaccone; Giorgio Giaccone; Fabrizio Tagliavini; Daniela Perani
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

4.  Early Stages of RNA-Mediated Conversion of Human Prions.

Authors:  Emilia A Lubecka; Ulrich H E Hansmann
Journal:  J Phys Chem B       Date:  2022-08-16       Impact factor: 3.466

5.  Prion protein inhibits fast axonal transport through a mechanism involving casein kinase 2.

Authors:  Emiliano Zamponi; Fiamma Buratti; Gabriel Cataldi; Hector Hugo Caicedo; Yuyu Song; Lisa M Jungbauer; Mary J LaDu; Mariano Bisbal; Alfredo Lorenzo; Jiyan Ma; Pablo R Helguera; Gerardo A Morfini; Scott T Brady; Gustavo F Pigino
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

6.  Mutations Alter RNA-Mediated Conversion of Human Prions.

Authors:  Erik J Alred; Izra Lodangco; Jennifer Gallaher; Ulrich H E Hansmann
Journal:  ACS Omega       Date:  2018-04-09

7.  RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.

Authors:  James A Carroll; Brent Race; Katie Williams; James Striebel; Bruce Chesebro
Journal:  Mol Brain       Date:  2020-05-07       Impact factor: 4.041

Review 8.  Axonal changes in experimental prion diseases recapitulate those following constriction of postganglionic branches of the superior cervical ganglion: a comparison 40 years later.

Authors:  Paweł P Liberski
Journal:  Prion       Date:  2019-01       Impact factor: 3.931

Review 9.  Metals in ALS TDP-43 Pathology.

Authors:  Lassi Koski; Cecilia Ronnevi; Elina Berntsson; Sebastian K T S Wärmländer; Per M Roos
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

10.  Prion peptide-mediated calcium level alteration governs neuronal cell damage through AMPK-autophagy flux.

Authors:  Ji-Hong Moon; Sang-Youel Park
Journal:  Cell Commun Signal       Date:  2020-07-11       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.